Skip to main content

Management of attention deficit hyperactivity disorder (ADHD) in primary care for school age children and adolescents

CBE ID
0107
1.4 Project
Endorsed
Endorsement Status
1.1 New or Maintenance
E&M Cycle
Is Under Review
No
1.3 Measure Description

Percentage of patients, aged 6-18 years old, treated with psychostimulant medication for the diagnosis of attention deficit hyperactivity disorder (ADHD) whose medical record contains documentation of follow-up visits at least twice a year that include height, weight, a discussion of medication, a discussion of school progress and a care plan.

        • 1.14 Numerator

          Number of patients, aged 6-18 years, diagnosed with ADHD and prescribed psychostimulant medication whose medical record contains documentation of at least two follow-up visits within a year medication was prescribed and the following components were discussed at each of the visits: height, weight, a discussion of medication, a discussion of school progress and a care plan.

          Documented is defined as any evidence in the medical record that at least 2 follow-up visits occur in the 12 months since psychostimulant medication prescription date. Each follow-up visit for ADHD includes documentation of the following twice a year: height, weight, a discussion of medication, a discussion of school progress, and a care plan discussion.

        • 1.15 Denominator

          Number of patients, aged 6-18 years, diagnosed with ADHD and prescribed a psychostimulant medication in the past 12 months. For this measure, count medication initiation date as the start of a 12-month period.

        • Exclusions

          None.

        • Most Recent Endorsement Activity
          Measure Retired and Endorsement Removed Behavioral Health Project 2013-2015
          Initial Endorsement
          Last Updated
          Removal Date